(Q40188612)

18 September 2017

Constrictive bronchiolitis obliterans: the fibrotic airway disorder (English)

1 reference

18 September 2017

0 references

bronchiolitis obliterans

1 reference

Gary R Epler

1

1 reference

18 September 2017

1 August 2007

1 reference

Expert Review of Respiratory Medicine

18 September 2017

1 reference

18 September 2017

1

1 reference

18 September 2017

1

1 reference

18 September 2017

139-147

1 reference

18 September 2017

Bronchiolar disorders.

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Histopathology of bronchiolar disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

21 January 2018

Bronchiolitis, an update

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Comparative clinicopathology of obliterative bronchiolitis and diffuse panbronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Bronchiolitis: the pathologist's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Miscellaneous causes of bronchiolitis: inhalational, infectious, drug-induced, and idiopathic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Bronchiolitis obliterans following exposure to sulfur mustard: chest high resolution computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Effect of gamma interferon on lung function of mustard gas exposed patients, after 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Clinical bronchiolitis obliterans in workers at a microwave-popcorn plant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Bronchiolitis obliterans syndrome in popcorn production plant workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

World Trade Center dyspnea: bronchiolitis obliterans with functional improvement: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Outbreak of Bronchiolitis obliterans associated with consumption of Sauropus androgynus in Japan--alert of food-associated pulmonary disorders from Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Obliterative bronchiolitis complicating bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Pulmonary complications in bone marrow transplantation: a practical approach to diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Obliterative bronchiolitis in haematopoietic stem cell transplantation: can it be treated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Bronchiolitis obliterans following haematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Severe airflow obstruction and eosinophilic lung disease after Stevens-Johnson syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Charcoal lung. Bronchiolitis obliterans after aspiration of activated charcoal

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Bronchiolitis obliterans after human lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Bronchiolitis obliterans syndrome: risk factors and therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Lung transplantation in patients 60 years and older: results, complications, and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Pathologic correlates of bronchiolitis obliterans syndrome in pulmonary retransplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Prognostic value of bronchiolitis obliterans syndrome stage 0-p in single-lung transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Mechanisms of airway obliteration after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Macrolides: a treatment alternative for bronchiolitis obliterans organizing pneumonia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Azithromycin: a plea for multicenter randomized studies in lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Rapamycin in lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Pirfenidone: anti-fibrotic agent with a potential therapeutic role in the management of transplantation patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Performance of long-term CT monitoring in diagnosing bronchiolitis obliterans after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

Bronchiolitis obliterans following lung transplantation: early detection using computed tomographic scanning

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.1.1.139

21 January 2018

Identifiers

DOI

10.1586/17476348.1.1.139

1 reference

18 September 2017

1 reference

PubMed ID

20477273